Nurix Stock Volatility

NRIX
 Stock
  

USD 12.99  0.66  5.35%   

We consider Nurix Therapeutics not too volatile. Nurix Therapeutics has Sharpe Ratio of 0.0369, which conveys that the firm had 0.0369% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Nurix Therapeutics, which you can use to evaluate the future volatility of the firm. Please verify Nurix Therapeutics Downside Deviation of 5.13, risk adjusted performance of 0.0143, and Mean Deviation of 3.89 to check out if the risk estimate we provide is consistent with the expected return of 0.19%.
  
Nurix Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Nurix daily returns, and it is calculated using variance and standard deviation. We also use Nurix's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Nurix Therapeutics volatility.

540 Days Market Risk

Not too volatile

Chance of Distress

540 Days Economic Sensitivity

Actively responds to the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Nurix Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Nurix Therapeutics at lower prices. For example, an investor can purchase Nurix stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Nurix Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Nurix Therapeutics

+0.82CMXHFCslPairCorr
+0.82CSLLYCsl Ltd ADRPairCorr

Nurix Therapeutics Market Sensitivity And Downside Risk

Nurix Therapeutics' beta coefficient measures the volatility of Nurix stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Nurix stock's returns against your selected market. In other words, Nurix Therapeutics's beta of 1.53 provides an investor with an approximation of how much risk Nurix Therapeutics stock can potentially add to one of your existing portfolios.
Nurix Therapeutics exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Nurix Therapeutics individually to make sure intended market timing strategies and available technical indicators are consistent with their estimates about Nurix Therapeutics future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nurix Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nurix Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
3 Months Beta |Analyze Nurix Therapeutics Demand Trend
Check current 90 days Nurix Therapeutics correlation with market (DOW)

Nurix Beta

    
  1.53  
Nurix standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  5.03  
It is essential to understand the difference between upside risk (as represented by Nurix Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Nurix Therapeutics' daily returns or price. Since the actual investment returns on holding a position in nurix stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Nurix Therapeutics.

Using Nurix Put Option to Manage Risk

Put options written on Nurix Therapeutics grant holders of the option the right to sell a specified amount of Nurix Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Nurix Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Nurix Therapeutics' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Nurix Therapeutics will be realized, the loss incurred will be offset by the profits made with the option trade.

Nurix Therapeutics' PUT expiring on 2022-10-21

   Profit   
Share
       Nurix Therapeutics Price At Expiration  

Current Nurix Therapeutics Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
2022-10-21 PUT at $25.0-0.62820.033952022-10-2110.1 - 14.59.75View
Put
2022-10-21 PUT at $17.5-0.58140.048412022-10-213.0 - 6.92.6View
Put
2022-10-21 PUT at $15.0-0.88840.102642022-10-210.5 - 5.01.6View
Put
2022-10-21 PUT at $12.5-0.47890.1488112022-10-210.85 - 1.450.9View
View All Nurix Therapeutics Options

Nurix Therapeutics Stock Volatility Analysis

Volatility refers to the frequency at which Nurix Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Nurix Therapeutics' price changes. Investors will then calculate the volatility of Nurix Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Nurix Therapeutics' volatility:

Historical Volatility

This type of stock volatility measures Nurix Therapeutics' fluctuations based on previous trends. It's commonly used to predict Nurix Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Nurix Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Nurix Therapeutics' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Developed by Larry Williams, the Weighted Close is the average of Nurix Therapeutics high, low and close of a chart with the close values weighted twice. It can be used to smooth an indicator that normally takes only Nurix Therapeutics closing price as input.
.

Nurix Therapeutics Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.5303 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Nurix Therapeutics will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nurix Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nurix Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nurix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has an alpha of 0.1338, implying that it can generate a 0.13 percent excess return over DOW after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Nurix Therapeutics' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how nurix stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Nurix Therapeutics Price Volatility?

Several factors can influence a Stock's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Nurix Therapeutics Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nurix Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nurix Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nurix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Given the investment horizon of 90 days the coefficient of variation of Nurix Therapeutics is 2712.42. The daily returns are distributed with a variance of 25.29 and standard deviation of 5.03. The mean deviation of Nurix Therapeutics is currently at 3.84. For similar time horizon, the selected benchmark (DOW) has volatility of 1.15
α
Alpha over DOW
0.13
β
Beta against DOW1.53
σ
Overall volatility
5.03
Ir
Information ratio 0.0186

Nurix Therapeutics Stock Return Volatility

Nurix Therapeutics historical daily return volatility represents how much of Nurix Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 5.029% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 1.1057% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
       Timeline  

About Nurix Therapeutics Volatility

Volatility is a rate at which the price of Nurix Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Nurix Therapeutics may increase or decrease. In other words, similar to Nurix's beta indicator, it measures the risk of Nurix Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Nurix Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company was incorporated in 2009 and is headquartered in San Francisco, California. Nurix Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.

Nurix Therapeutics Investment Opportunity

Nurix Therapeutics has a volatility of 5.03 and is 4.53 times more volatile than DOW. 43  of all equities and portfolios are less risky than Nurix Therapeutics. Compared to the overall equity markets, volatility of historical daily returns of Nurix Therapeutics is lower than 43 () of all global equities and portfolios over the last 90 days. Use Nurix Therapeutics to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Nurix Therapeutics to be traded at $16.24 in 90 days.

Weak diversification

The correlation between Nurix Therapeutics and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Nurix Therapeutics Additional Risk Indicators

The analysis of Nurix Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Nurix Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Nurix Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Nurix Therapeutics Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Nurix Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Nurix Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Nurix Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Nurix Therapeutics.
Additionally, see Correlation Analysis. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for analysis

When running Nurix Therapeutics price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Nurix Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix Therapeutics. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nurix Therapeutics is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Nurix Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix Therapeutics' market value can be influenced by many factors that don't directly affect Nurix Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Nurix Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.